Fenoksipropazin

Fenoksipropazin
(IUPAC) ime
	(1-metil-2-fenoksi-etil)hidrazin
Klinički podaci
Identifikatori
CAS broj	3818-37-9
ATC kod	nije dodeljen
PubChem	71467
ChemSpider	64548
UNII	8E92V52324
ChEMBL	CHEMBL1909286
Hemijski podaci
Formula	C9H14N2O
Mol. masa	166,22 g/mol}
SMILES	eMolekuli & PubHem
InChI
	InChI=QNEXFJFTGQBXBJ-UHFFFAOYSA-N ; Key: QNEXFJFTGQBXBJ-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	℞ Prescription only
Način primene	Oralno

Fenoksipropazin (prodajno ime Drazin) je ireverzibilni i neselektivni inhibitor monoaminoksidaze (MAOI) iz hidrazinske hemijske klase. On je uveden u upotrebu kao antidepresiv 1961, ali je naknadno povućen sa tržišta 1966. zbog moguće pojave hepatotoksičnosti.^[5]^[6]^[7]^[8]^[9]

Vidi još[uredi - уреди | uredi izvor]

Hidrazin (antidepresiv)

Reference[uredi - уреди | uredi izvor]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. http://www.jcheminf.com/content/2/1/3. edit
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ LEAHY MR, ROSE JT, PLOWMAN R (April 1963). „A preliminary study of phenoxypropazine in the treatment of depression”. The American Journal of Psychiatry 119: 986–7. PMID 13928824. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=13928824.
↑ IMLAH NW (May 1963). „Preliminary report on phenoxypropazine”. The American Journal of Psychiatry 119: 1091–2. PMID 13956423. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=13956423.
↑ ROSE JT, LEAHY MR, PLOWMAN R (October 1963). „A comparison of phenoxypropazine and amitriptyline in depression”. The American Journal of Psychiatry 120: 393–5. PMID 14069469. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=14069469.
↑ ROSE JT (March 1964). „Phenoxypropazine and chlordiazepoxide in depression”. The American Journal of Psychiatry 120: 899–900. PMID 14129290. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=14129290.
↑ MCWHINNEY IR, MORRELL DC (January 1965). „Treatment of mild endogenous depression with a monoamine oxidase inhibitor: a controlled trial in general practice”. The Journal of the College of General Practitioners 9: 95–9. PMC 1878242. PMID 14254271. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1878242/.

Spoljašnje veze[uredi - уреди | uredi izvor]

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. http://www.jcheminf.com/content/2/1/3. edit

[4] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[pmid13928824-5] LEAHY MR, ROSE JT, PLOWMAN R (April 1963). „A preliminary study of phenoxypropazine in the treatment of depression”. The American Journal of Psychiatry 119: 986–7. PMID 13928824. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=13928824.

[pmid13956423-6] IMLAH NW (May 1963). „Preliminary report on phenoxypropazine”. The American Journal of Psychiatry 119: 1091–2. PMID 13956423. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=13956423.

[pmid14069469-7] ROSE JT, LEAHY MR, PLOWMAN R (October 1963). „A comparison of phenoxypropazine and amitriptyline in depression”. The American Journal of Psychiatry 120: 393–5. PMID 14069469. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=14069469.

[pmid14129290-8] ROSE JT (March 1964). „Phenoxypropazine and chlordiazepoxide in depression”. The American Journal of Psychiatry 120: 899–900. PMID 14129290. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=14129290.

[pmid14254271-9] MCWHINNEY IR, MORRELL DC (January 1965). „Treatment of mild endogenous depression with a monoamine oxidase inhibitor: a controlled trial in general practice”. The Journal of the College of General Practitioners 9: 95–9. PMC 1878242. PMID 14254271. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1878242/.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

Fenoksipropazin

Vidi još[uredi - уреди | uredi izvor]

Reference[uredi - уреди | uredi izvor]

Spoljašnje veze[uredi - уреди | uredi izvor]

Navigacijski meni

Traži-Тражи